1 Min Read
Feb 13 (Reuters) - Bayer:
* SAYS EYLEA APPROVED IN CHINA FOR TREATMENT OF DIABETIC MACULAR EDEMA, FIRST APPROVAL FOR EYLEA IN CHINA
Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.